BG28259A3 - Метод за получаване на n-(4-пиперидинил)-n-фенил-амиди и карбамати - Google Patents

Метод за получаване на n-(4-пиперидинил)-n-фенил-амиди и карбамати

Info

Publication number
BG28259A3
BG28259A3 BG032601A BG3260176A BG28259A3 BG 28259 A3 BG28259 A3 BG 28259A3 BG 032601 A BG032601 A BG 032601A BG 3260176 A BG3260176 A BG 3260176A BG 28259 A3 BG28259 A3 BG 28259A3
Authority
BG
Bulgaria
Prior art keywords
carbamates
piperidinyl
amides
phenyl
preparation
Prior art date
Application number
BG032601A
Other languages
Bulgarian (bg)
English (en)
Inventor
Paul Janssen
George Vandaele
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG28259A3 publication Critical patent/BG28259A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
BG032601A 1975-03-14 1976-03-12 Метод за получаване на n-(4-пиперидинил)-n-фенил-амиди и карбамати BG28259A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55851175A 1975-03-14 1975-03-14
US05/648,685 US3998834A (en) 1975-03-14 1976-01-13 N-(4-piperidinyl)-n-phenylamides and -carbamates

Publications (1)

Publication Number Publication Date
BG28259A3 true BG28259A3 (bg) 1980-03-25

Family

ID=27071767

Family Applications (1)

Application Number Title Priority Date Filing Date
BG032601A BG28259A3 (bg) 1975-03-14 1976-03-12 Метод за получаване на n-(4-пиперидинил)-n-фенил-амиди и карбамати

Country Status (28)

Country Link
US (1) US3998834A (cs)
JP (1) JPS5946217B2 (cs)
AT (1) AT359493B (cs)
AU (1) AU503632B2 (cs)
BG (1) BG28259A3 (cs)
CA (1) CA1080232A (cs)
CH (1) CH629486A5 (cs)
CZ (1) CZ278060B6 (cs)
DE (1) DE2610228A1 (cs)
DK (1) DK148960C (cs)
ES (1) ES446034A1 (cs)
FI (1) FI61481C (cs)
FR (1) FR2303546A1 (cs)
GB (1) GB1538938A (cs)
HU (1) HU172963B (cs)
IE (1) IE42512B1 (cs)
IL (1) IL49204A (cs)
IT (1) IT1057988B (cs)
LU (1) LU74511A1 (cs)
NL (1) NL185279C (cs)
NO (1) NO146162C (cs)
NZ (1) NZ180096A (cs)
PH (1) PH12746A (cs)
PL (1) PL102474B1 (cs)
PT (1) PT64898B (cs)
SE (1) SE426486B (cs)
SU (1) SU1227109A3 (cs)
YU (1) YU39960B (cs)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179569A (en) * 1975-03-14 1979-12-18 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-N-phenylamides
US4208418A (en) * 1975-09-23 1980-06-17 Janssen Pharmaceutica N.V. N-Aryl-N-(1-alkyl-4-piperidinyl)arylacetamides
US4225606A (en) * 1975-09-23 1980-09-30 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)arylacetamides
FR2389622B1 (cs) * 1977-05-05 1982-05-21 Janssen Pharmaceutica Nv
US4167574A (en) * 1978-03-13 1979-09-11 Janssen Pharmaceutica, N.V. N-phenyl-N-(4-piperidinyl)amides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
FR2608602A1 (fr) * 1986-12-23 1988-06-24 Cerm Cent Europ Rech Mauvernay Nouvelles 3-piperidineamines ou 3-azepineamines substituees, leur preparation et leurs applications en therapeutique
US4791121A (en) * 1987-11-02 1988-12-13 The Boc Group, Inc. 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4957929A (en) * 1987-11-02 1990-09-18 Boc, Inc. 4-phenyl-4-[N-(phenyl)amido]piperidine compounds and pharmaceutical compositions employing such compounds
US5013742A (en) * 1987-11-02 1991-05-07 Boc, Inc. 4-phenyl-4-N-(phenyl) amido piperidine derivatives and pharmaceutical compositions and method employing such compounds
USRE33495E (en) * 1987-11-02 1990-12-18 Boc, Inc. Stereoselective preparation of 3-substituted-4-anilino-piperidine compounds and derivatives
US4849521A (en) * 1987-11-02 1989-07-18 Boc, Inc. Stereoselective preparation of 3-substituted-4-piperidine compounds and derivatives
US4921864A (en) * 1987-11-02 1990-05-01 Boc, Inc. 4-Phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4801615A (en) * 1987-12-31 1989-01-31 The Boc Group, Inc. 4-heterohexacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4791120A (en) * 1987-12-31 1988-12-13 The Boc Group, Inc. 4-heteropentacyclic-4-[N-(phenyl)amino] piperidine derivatives and pharmaceutical compositions and method employing such compounds
US5019583A (en) * 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5145967A (en) * 1989-04-20 1992-09-08 Anaquest, Inc. Method for preparing 4-alkoxyalkyl-4-phenylaminopiperdines and derivatives thereof
US5053411A (en) * 1989-04-20 1991-10-01 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
USRE34201E (en) * 1989-04-20 1993-03-23 Anaquest, Inc. N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
US4994471A (en) * 1989-05-12 1991-02-19 Boc, Inc. N-aryl-N-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US5100903A (en) * 1989-05-12 1992-03-31 Anaquest, Inc. N-aryl-n-(1-substituted-3-alkoxy-4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
US4939161A (en) * 1989-05-12 1990-07-03 Boc, Inc. Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides
US5126455A (en) * 1989-12-13 1992-06-30 Glaxo Inc. Preparation of substituted alkali metal piperidine-4-carboxylates
US5039804A (en) * 1989-12-13 1991-08-13 Glaxo Inc. Preparation of substituted alkali metal piperidine-4-carboxylates
US5214148A (en) * 1990-12-18 1993-05-25 Glaxo Inc. Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides
US5130321A (en) * 1990-12-18 1992-07-14 Glaxo Inc. Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
GB9316863D0 (en) * 1993-08-13 1993-09-29 Glaxo Group Ltd Chemical process
US5489689A (en) * 1993-09-30 1996-02-06 Mallinckrodt Chemical, Inc. Preparation of piperidine derivatives
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
CA2369691A1 (en) * 1999-04-09 2000-10-19 Yutaka Miyazaki 4-hydroxypiperidine derivatives having antiarrhythmic effect
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en) * 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
WO2001040184A2 (en) * 1999-12-06 2001-06-07 Mallinckrodt Inc. Methods for the syntheses of alfentanil, sufentanil and remifentanil
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
JPWO2006030931A1 (ja) * 2004-09-14 2008-05-15 日本ケミファ株式会社 Ｎ−置換−ｎ−（４−ピペリジニル）アミド誘導体
JP2008088057A (ja) * 2005-03-23 2008-04-17 Nippon Chemiphar Co Ltd Ｎ−置換−ｎ−（４−ピペリジニル）アミド誘導体
CA2630324A1 (en) * 2005-11-17 2007-05-31 Mallinckrodt Inc. Process for synthesizing remifentanil
US20080312448A1 (en) * 2006-01-24 2008-12-18 Cheng Brian K Process for Synthesizing Remifentanil
EP1867635A1 (en) * 2006-06-15 2007-12-19 Kern Pharma, S.L. Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
WO2008005423A1 (en) * 2006-07-03 2008-01-10 Cambrex Charles City, Inc. Improved method of making sufentanil
EP2125730A2 (en) * 2006-11-29 2009-12-02 Mallinckrodt Inc. New process for remifentanil synthesis
US20100056574A1 (en) * 2008-09-04 2010-03-04 Mallinckrodt Inc. Crystalline Forms of Sufentanil
US8299258B2 (en) * 2008-11-04 2012-10-30 Cambrex Charles City Method of making piperidine derivatives
US8946433B2 (en) 2010-09-17 2015-02-03 Mallinckrodt Llc Process for the preparation of sufentanil base and related compounds
EP2455377B1 (de) 2010-11-11 2014-07-09 hameln rds gmbh Synthese von Fentanyl Analoga
AU2011336467A1 (en) 2010-12-01 2013-07-04 Spinal Modulation, Inc. Agent delivery systems for selective neuromodulation
HK1222555A1 (zh) * 2013-03-13 2017-07-07 President And Fellows Of Harvard College 钉合且缝合的多肽及其用途
EP3233077A4 (en) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
MX381426B (es) 2015-05-27 2025-03-12 Mallinckrodt Llc Preparacion de citrato de sufentanilo y base de sufentanilo.
CN106854203B (zh) * 2015-12-08 2020-12-01 江苏恩华药业股份有限公司 枸橼酸舒芬太尼的新晶型及其制备方法
EP3199523B1 (en) 2016-01-29 2018-08-15 Bioka s. r.o. The new process for producing n-phenyl-n-(4-piperidinyl) amide derivatives such as remifentanil and carfentanil
CN108503579B (zh) * 2018-03-28 2021-03-26 南京医科大学 芬太尼类似物及其应用
CN113214139B (zh) * 2020-02-03 2022-03-04 江苏谛奇医药科技有限公司 哌啶酰胺类衍生物及其制备方法、其药物组合物、其单晶培养方法及其应用
EP4196478A1 (en) 2020-08-14 2023-06-21 Novartis AG Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
CN114262320A (zh) * 2021-12-28 2022-04-01 宜昌人福药业有限责任公司 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623427A (cs) * 1961-10-10
US3171838A (en) * 1961-10-10 1965-03-02 Res Lab Dr C Janssen N V Aroylalkyl and hydroxyaralkyl derivatives of 4-(n-arylalkanamido)-piperidines and related compounds

Also Published As

Publication number Publication date
DK148960C (da) 1986-06-23
ES446034A1 (es) 1977-10-16
DK110376A (da) 1976-09-15
IT1057988B (it) 1982-03-30
NZ180096A (en) 1978-06-02
AU503632B2 (en) 1979-09-13
CZ278060B6 (en) 1993-08-11
JPS51115478A (en) 1976-10-12
NO760591L (cs) 1976-09-15
NO146162C (no) 1982-08-11
YU65276A (en) 1982-08-31
FI61481C (fi) 1982-08-10
IL49204A0 (en) 1976-05-31
CA1080232A (en) 1980-06-24
LU74511A1 (cs) 1976-09-01
NL185279C (nl) 1990-03-01
HU172963B (hu) 1979-01-28
NO146162B (no) 1982-05-03
DK148960B (da) 1985-12-02
YU39960B (en) 1985-06-30
NL7602612A (nl) 1976-09-16
SE7602740L (sv) 1976-09-15
FI760646A7 (cs) 1976-09-15
GB1538938A (en) 1979-01-24
JPS5946217B2 (ja) 1984-11-10
DE2610228C2 (cs) 1990-04-05
SU1227109A3 (ru) 1986-04-23
PT64898A (en) 1976-04-01
FR2303546A1 (fr) 1976-10-08
IE42512L (en) 1976-09-14
PL102474B1 (pl) 1979-03-31
PH12746A (en) 1979-08-09
IL49204A (en) 1979-11-30
SE426486B (sv) 1983-01-24
CH629486A5 (de) 1982-04-30
AT359493B (de) 1980-11-10
ATA184676A (de) 1980-04-15
PT64898B (en) 1977-08-18
NL185279B (nl) 1989-10-02
AU1200676A (en) 1977-09-22
DE2610228A1 (de) 1976-09-30
US3998834A (en) 1976-12-21
FR2303546B1 (cs) 1980-11-28
CZ163276A3 (en) 1993-03-17
FI61481B (fi) 1982-04-30
IE42512B1 (en) 1980-08-27

Similar Documents

Publication Publication Date Title
BG28259A3 (bg) Метод за получаване на n-(4-пиперидинил)-n-фенил-амиди и карбамати
BG28065A4 (en) Method of obtaining of 2-phenyl-3-aroylbenzothiophenes
BG31225A3 (bg) Метод за получаване на ациланилидни производни
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG29135A3 (en) Method of obtaining of acyclic and alycyclic n- substituated halo- 2- pyrolidinon
BG33296A3 (bg) Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG31949A3 (en) Method for obtaining derivatives of phenyl- 2- indol
BG27901A3 (bg) Метод за получаване на n-(метокси-метил-фурил-метил)-6-7-бензоморфани и бензоморфинапи
BG37993A3 (bg) Метод за получаване на 4-хинолонови производни
BG33885A3 (en) Method for producing the amids of lisergine acid
BG28706A4 (en) Method of obtaining of n- substituated halogenacetamilides
BG31224A3 (bg) Метод за получаване на производни на енкефалина
BG28072A4 (bg) Метод за получаване на 1 n заместени канамицинови производни
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG33275A3 (bg) Метод за получаване на бензофенони и техни производни
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG34036A3 (bg) Метод за получаване на пропаргил -2- фениламино- имидазолини-(2) и техните присъединителни с киселина соли
BG28413A3 (bg) Метод за получаване на n-заместени лактами
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG31504A3 (bg) Метод за получаване на депостероидни естери
BG35466A3 (bg) Метод за получаване на производни на клавулановата киселина
BG28574A3 (bg) Метод за получаване на 4 дифенилметилен 1 хидрокси бензол пиперидини
BG31503A3 (en) Method for obtaining the derivatives of octahjdroindolhinolzine
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони